Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans
Lindsey R. Baden(Brigham and Women's Hospital), Dan H. Barouch(Beth Israel Deaconess Medical Center), Stephen R. Walsh(Beth Israel Deaconess Medical Center), Peter Abbink(Beth Israel Deaconess Medical Center), Edith Swann(National Institutes of Health), Mark Wolff(Emmes (United States)), Brian A. Engelson, Brittany R. Carey(Hadassah Medical Center), Danny A. Milner(Union for International Cancer Control), Mo Weijtens(Janssen (Netherlands)), Jinyan Liu(Beth Israel Deaconess Medical Center), Hayley Loblein(Emmes (United States)), Maria Grazia Pau, Benjamin J. Chen(Bristol-Myers Squibb (United States)), Michael S. Seaman(Beth Israel Deaconess Medical Center), Kyle L. Viani(Brigham and Women's Hospital), Matthew D. Stachler(University of California, San Francisco), Hualin Li(Harvard University), Caroline A. Miller(Hadassah Medical Center), Jennifer Johnson(Northwestern University), Kevin Golden(Brigham and Women's Hospital), Jane A. Kleinjan(Brigham and Women's Hospital), Raphael Dolin(Beth Israel Deaconess Medical Center), Lauren Peter(Beth Israel Deaconess Medical Center)
Cited by 64
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
|Science|2020|1.1k